However, due to its antiviral and immunnomodulatory capacity, IFN-α has also been used to treat chronic hepatitis C (HCV) and recombinant IFN is used as an immunomodulatory treatment for some cancers including melanoma and renal cell carcinoma [20]. This evidence concerns the gene IFNA1 and melanoma.